Brain Tumor Center Team

Steven D. Chang, MD
Professor of Neurosurgery
Rober C and Jeannette Powel Neurosciences Professor

Dr. Steven Chang received his medical degree from Stanford University. He completed his neurosurgical training at Stanford with a focus on stereotactic radiosurgery, cerebrovascular disease, and brain and spinal tumors. He is recognized as an expert in Cyberknife radiosurgery and surgical resection of brain tumors. Dr. Chang is a research interest in neurogenetics and proteomics.

Juan C. Fernandez-Miranda, MD
Professor of Neurosurgery

Dr. Juan Fernandez-Miranda is Professor of Neurosurgery and Surgical Director of the Stanford Brain Tumor, Skull Base, and Pituitary Centers. He is internationally renowned for his expertise in minimally invasive brain surgery, endoscopic skull base and pituitary surgery, open skull base surgery, and complex brain tumor surgery. He has performed over a thousand endoscopic endonasal operations for pituitary tumors and other skull base lesions. He is highly regarded for his precise knowledge of the intricate anatomy of the white matter tracts required to maximize resection and minimize morbidity on high and low grade glioma patients. 

Nancy Fischbein, MD
Professor of Radiology - Diagnostic Radiology

Dr. Fischbein earned her medical degree at Harvard Medical School and completed her training in Diagnostic Radiology and her neuroradiology fellowship at the University of California-San Francisco. She is board certified in Diagnostic Radiology and holds a Certificate of Added Qualification in Neuroradiology. Dr. Fischbein's research interests include imaging of brain tumors using advanced MR-based modalities, as well as imaging of processes that affect the skull base and cranial nervesThis is example text for the text & image component. Too add or edit text here, double or right-click to bring up the editor.

Iris C. Gibbs, MD, FACR
Professor of Radiation Oncology - Radiation Therapy

Dr. Gibbs is a board-certified radiation oncologist who specializes in the treatment of CNS tumors. Her research focuses on developing new radiation techniques to manage brain and spinal tumors in adults and children. Dr. Gibbs has gained worldwide acclaim for her expertise in Cyberknife robotic radiosurgery.

Melanie G. Hayden Gephart, MD
Professor of Neurosurgery

Melanie Hayden Gephart, MD, MAS is an Assistant Professor in the Department of Neurosurgery at Stanford University School of Medicine. Dr. Hayden Gephart’s research and clinical expertise in the treatment of central nervous system tumors and conditions is an important addition to Stanford Health Care. Her translational research focuses on understanding and halting the mechanisms driving tumor growth in the brain and spinal cord. Dr. Hayden Gephart’s work as a neurosurgeon and scientist help to develop and implement new treatments for patients with brain tumors.

Dr. Hayden Gephart received her medical and masters degrees from University of California at San Diego (UCSD) School of Medicine. She completed her residency and served as Chief Resident in Neurosurgery at Stanford University Hospital and Clinics. Dr. Hayden Gephart finished her Research Fellowship from the Departments of Developmental Biology, Genetics, Bioengineering, and Neurosurgery at Stanford University.

Laurence Katznelson, MD
Professor of Neurosurgery and Medicine
Director, Endocrinology Fellowship Training Program
Medical Director, Stanford Pituitary Center

Laurence Katznelson, MD received his medical degree from the University of California, Los Angeles and performed his internship and residency in Internal Medicine at the Hospital of the University of Pennsylvania, Philadelphia.  He then performed a fellowship in Endocrinology and Metabolism at the Massachusetts General Hospital, Boston.  Dr. Katznelson is currently the Medical Director of the Pituitary Center at Stanford University Medical Center, Stanford, California.  Dr. Katznelson is a Professor of Neurosurgery and Medicine at Stanford University School of Medicine.  At Stanford University, he is the Program Director for the Endocrinology fellowship training program.  He is a member of the Editorial Boards for Frontiers in Medicine, and  Pituitary, and is an ad hoc reviewer for the Journal of Clinical Endocrinology and Metabolism.  In the Endocrine Society, Dr. Katznelson has served as Chair of the Special Programs Committee and member of the Scientific and Educational Programs Core Committee. He has served as Chair of the Task Forces for writing clinical guidelines for the approach to acromegaly for both the American Association of Clinical Endocrinologists and The Endocrine Society. He has served as an ad hoc member of NIH study sections.  Dr. Katznelson has a long standing clinical and research interest in the pathophysiology and treatment of pituitary disease.

Gordon Li, MD
Professor of Neurosurgery

Gordon Li graduated from Brown University with honors in neuroscience and received his MD at UC Davis School of Medicine.  He completed his neurosurgical residency at Stanford University School of Medicine and was hired on to help build the brain tumor center at Stanford University School of Medicine.  His clinical interests include improving surgical techniques for brain tumor surgery, immunotherapy for the treatment of brain cancer, and novel uses for stereotactic radiosurgery.  His research laboratory studies the biology of brain tumors with the goal of developing novel therapeutics for the treatment of malignant brain tumors and translating that research into clinical trials.

Michael Lim, MD
Professor of Neurosurgery
Chair, Department of Neurosurgery

Dr. Lim’s clinical interests include the treatment of benign and malignant brain tumors, with special interest in gliomas, meningiomas, metastatic tumors, and skull base tumors. Dr. Lim also specializes in surgical treatments for trigeminal neuralgia. During his time at Johns Hopkins, Dr. Lim built one of the largest brain tumor and trigeminal neuralgia practices and utilized the most advanced surgical technologies and techniques for his patients. As a passionate voice for patient experience, he has been recognized by his peers and patients for his integrity and compassionate care, including a Service Excellence Award from HealthNetwork Foundation.

Michelle Monje, MD, PhD
Professor of Neurology and Neurological Sciences

Michelle Monje, MD PhD, is an Assistant Professor of Neurology and Neuro-Oncology at Stanford University. Dr. Monje received her BA from Vassar College and her MD and PhD from Stanford University. She completed her residency training in neurology at the Massachusetts General Hospital/Brigham and Women's Hospital/Harvard Medical School Partners program. Dr. Monje then returned to Stanford to complete a clinical fellowship in pediatric neuro-oncology and a post-doctoral fellowship. Dr Monje now balances clinical practice with a robust research program. She is actively involved in the Pediatric Brain Tumor Consortium and serves as the Chair for the Brainstem Glioma Working Group. Her laboratory focuses on the molecular and cellular mechanisms of postnatal neurodevelopment in health and disease. Dr Monje is particularly interested in the roles for neural precursor cell function and dysfunction in the origins of pediatric brain tumors and the consequences of cancer treatment.

Seema Nagpal, MD
Clinical Associate Professor of Neurology and Neurologial Sciences

Dr. Nagpal earned her medical degree at the University of Pennsylvania, completed Neurology residency at University of California, San Francisco and Neuro-Oncology fellowship at Stanford University. Dr. Nagpal is focused on developing therapy that increases both quantity and quality of life for patients with primary brain tumors. She also has a special interest in neurologic complications of systemic cancer, such as brain and leptomeningeal metastases. Dr. Nagpal’s research efforts include clinical trials in glioma and collaborative projects to identify the genetic under-pinnings of brain metastases.

Lawrence Recht, MD
Professor of Neurology and Neurological Sciences
Director, Adult Neuro-Oncology

Dr. Lawrence Recht received his medical degree from Columbia University College of Physicians and Surgeons in New York City. He completed his training as a Resident in Neurology at Columbia Presbyterian, Neurological Institute of New York. His interest in helping people with brain tumors led him to additional training and completion of a Fellowship in Neuro-Oncology at Memorial Sloan Kettering Cancer Institute in New York.

As an attending in Neurology with a specialty in Neuro-Oncology, Dr. Recht moved to the University of Massachusetts Medical School where he spent 19 years caring for patients and working in his research lab to try to find a cure for brain tumor. During this time Dr. Recht became convinced that it was better for patients to find out how and why a brain tumor evolved so that it could be treated earlier rather than directing his efforts toward treating the tumor after it had already caused disability.

In 2004, Dr Recht relocated to Stanford to work on furthering his research on Early Detection of Brain Tumor and to develop an expanded Adult Neuro-Oncology Program. Belief in hope and quality of life drives Dr. Recht and his team's practice of caring for patients and families with brain tumor and neurologic complications of cancer. Clinical studies are also provided and available for patients with specific conditions who are interested in adding experimental treatments to their care.

Efforts in Dr. Recht's research laboratory are directed towards applying early detection strategies to the treatment of brain tumors. In addition, other work in his laboratory is directed at reversing the damaging side effects of treatment-related brain injury.

Lawrence M. Shuer, MD, FAAS
Professor of Neurosurgery, Vice Chair for Quality of the Neurosurgery Department at Stanford University

Dr. Lawrence M. Shuer received his medical degree from The University of Michigan in Ann Arbor, Michigan. He completed his training as a Resident in Neurosurgery at Stanford University. He then joined the faculty of Stanford Neurosurgery and has been caring for patients with Brain, Spinal Cord and Peripheral Nerve tumors for almost 30 years. He has served as Acting Chair of the Department of Neurosurgery, Chief of Staff of Stanford Hospital and Clinics and Associate Dean for Graduate Medical Affairs in the past. He participates actively in the Neuro-oncology tumor board.

Scott G. Soltys, MD
Associate Professor of Radiation Oncology - Radiation Therapy

Dr. Scott Soltys earned his medical degree from the University of Michigan, completing his residency in Radiation Oncology at Stanford University.  His clinical and research interests focus on the development of new treatments involving radiotherapy and radiosurgery for tumors of the brain and spine, as well as functional disorders such as trigeminal neuralgia.  His current clinical trials are investigating how to optimize the radiosurgical treatment of patients with large brain metastases and how to improve the quality of life of patients receiving radiotherapy for Glioblastoma Multiforme (GBM).

Reena Thomas, MD, PhD
Clinical Associate Professor of Neurology

Dr. Reena Thomas received her medical degree from Georgetown University School of Medicine in Washington, DC and her PhD from the City of Hope Graduate School in Duarte, California. She completed her training as a resident in Neurology as well as her fellowship training in Neuro-Oncology at Stanford University Hospital. Her research background and interests are focused on immune based cancer therapies and chemokine signaling in glioblastoma brain tumors. She has also been involved in advanced imaging studies of glioblastoma. She is the Director of the Adult Neuro Oncology Fellowship at Stanford.

Hannes Vogel, MD
Professor of Pathology
Associate Chair of Neuropathology, Department of Pathology

Dr. Vogel’s research interests include nerve and muscle pathology, mitochondrial diseases, pediatric neurooncology, and transgenic mouse pathology.  Dr. Vogel is the Associate Chair for Neuropathology, Department of Pathology at Stanford from 2005 to the present.